These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18596687)

  • 1. Evidence for beta1-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: implications for cocaine withdrawal.
    Rudoy CA; Reyes AR; Van Bockstaele EJ
    Neuropsychopharmacology; 2009 Apr; 34(5):1135-48. PubMed ID: 18596687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats.
    Rudoy CA; Van Bockstaele EJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1119-29. PubMed ID: 17513029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of CRF mRNA in the Rat Extended Amygdala Following Chronic Cocaine: Sex Differences and Effect of Delta Opioid Receptor Agonism.
    Connelly KL; Unterwald EM
    Int J Neuropsychopharmacol; 2020 Feb; 23(2):117-124. PubMed ID: 31867624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.
    Reyes BAS; Kravets JL; Connelly KL; Unterwald EM; Van Bockstaele EJ
    Brain Struct Funct; 2017 Mar; 222(2):1007-1026. PubMed ID: 27376372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
    Pollandt S; Liu J; Orozco-Cabal L; Grigoriadis DE; Vale WW; Gallagher JP; Shinnick-Gallagher P
    Eur J Neurosci; 2006 Sep; 24(6):1733-43. PubMed ID: 17004937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala.
    Scholl JL; Vuong SM; Forster GL
    Eur J Pharmacol; 2010 Oct; 644(1-3):80-7. PubMed ID: 20655906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
    Georgiou P; Zanos P; Garcia-Carmona JA; Hourani S; Kitchen I; Laorden ML; Bailey A
    Neuropharmacology; 2016 Jun; 105():520-532. PubMed ID: 26896754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala.
    Maj M; Turchan J; Smiałowska M; Przewłocka B
    Neuropeptides; 2003 Apr; 37(2):105-10. PubMed ID: 12747942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta1 adrenergic receptors in the bed nucleus of stria terminalis mediate differential responses to opiate withdrawal.
    Cecchi M; Capriles N; Watson SJ; Akil H
    Neuropsychopharmacology; 2007 Mar; 32(3):589-99. PubMed ID: 16823388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor mechanisms mediate corticotropin-releasing factor-induced long-term potentiation in the rat amygdala following cocaine withdrawal.
    Krishnan B; Centeno M; Pollandt S; Fu Y; Genzer K; Liu J; Gallagher JP; Shinnick-Gallagher P
    Eur J Neurosci; 2010 Mar; 31(6):1027-42. PubMed ID: 20377617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related alterations in emotional behaviors and amygdalar corticotropin-releasing factor (CRF) and CRF-binding protein expression in aged Fischer 344 rats.
    Pisarska M; Mulchahey JJ; Welge JA; Geracioti TD; Kasckow JW
    Brain Res; 2000 Sep; 877(2):184-90. PubMed ID: 10986331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats.
    Funk CK; O'Dell LE; Crawford EF; Koob GF
    J Neurosci; 2006 Nov; 26(44):11324-32. PubMed ID: 17079660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amygdaloid corticotropin-releasing factor is involved in the anxiolytic effect of acupuncture during ethanol withdrawal in rats.
    Zhao Z; Jin X; Wu Y; Yang X; Xu Y; Jiang JZ; Kim SC; Lee BH; Yang CH; Zhao R
    J Acupunct Meridian Stud; 2013 Oct; 6(5):234-40. PubMed ID: 24139460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the beta-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation.
    Roozendaal B; Schelling G; McGaugh JL
    J Neurosci; 2008 Jun; 28(26):6642-51. PubMed ID: 18579737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats.
    Pandey SC; Roy A; Zhang H
    Alcohol Clin Exp Res; 2003 Mar; 27(3):396-409. PubMed ID: 12658105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation.
    Zhou Y; Bendor JT; Yuferov V; Schlussman SD; Ho A; Kreek MJ
    Neuroscience; 2005; 134(4):1391-7. PubMed ID: 16039786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine.
    Zhou Y; Spangler R; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2003 May; 114(1):73-9. PubMed ID: 12782395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.
    Park PE; Vendruscolo LF; Schlosburg JE; Edwards S; Schulteis G; Koob GF
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1867-75. PubMed ID: 23590881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β1-Adrenoceptor in the Central Amygdala Is Required for Unconditioned Stimulus-Induced Drug Memory Reconsolidation.
    Zhu H; Zhou Y; Liu Z; Chen X; Li Y; Liu X; Ma L
    Int J Neuropsychopharmacol; 2018 Mar; 21(3):267-280. PubMed ID: 29216351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.